Pilot study for generating and assessing nomograms and decision curves analysis to predict clinically significant prostate cancer using only spatially registered multi-parametric MRI

BackgroundCurrent prostate cancer evaluation can be inaccurate and burdensome. To help non-invasive prostate tumor assessment, recent algorithms applied to spatially registered multi-parametric (SRMP) MRI extracted novel clinically relevant metrics, namely the tumor’s eccentricity (shape), signal-to...

Full description

Bibliographic Details
Main Authors: Rulon Mayer, Baris Turkbey, Peter Choyke, Charles B. Simone
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1066498/full
_version_ 1797944922809040896
author Rulon Mayer
Rulon Mayer
Baris Turkbey
Peter Choyke
Charles B. Simone
author_facet Rulon Mayer
Rulon Mayer
Baris Turkbey
Peter Choyke
Charles B. Simone
author_sort Rulon Mayer
collection DOAJ
description BackgroundCurrent prostate cancer evaluation can be inaccurate and burdensome. To help non-invasive prostate tumor assessment, recent algorithms applied to spatially registered multi-parametric (SRMP) MRI extracted novel clinically relevant metrics, namely the tumor’s eccentricity (shape), signal-to-clutter ratio (SCR), and volume.PurposeConduct a pilot study to predict the risk of developing clinically significant prostate cancer using nomograms and employing Decision Curves Analysis (DCA) from the SRMP MRI-based features to help clinicians non-invasively manage prostate cancer.MethodsThis study retrospectively analyzed 25 prostate cancer patients. MP-MRI (T1, T2, diffusion, dynamic contrast-enhanced) were resized, translated, and stitched to form SRMP MRI. Target detection algorithm [adaptive cosine estimator (ACE)] applied to SRMP MRI determines tumor’s eccentricity, noise reduced SCR (by regularizing or eliminating principal components (PC) from the covariance matrix), and volume. Pathology assessed wholemount prostatectomy for Gleason score (GS). Tumors with GS >=4+3 (<=3+4) were judged as “Clinically Significant” (“Insignificant”). Logistic regression combined eccentricity, SCR, volume to generate probability distribution. Nomograms, DCA used all patients plus training (13 patients) and test (12 patients) sets. Area Under the Curves for (AUC) for Receiver Operator Curves (ROC) and p-values evaluated the performance.ResultsCombining eccentricity (0.45 ACE threshold), SCR (3, 4 PCs), SCR (regularized, modified regularization) with tumor volume (0.65 ACE threshold) improved AUC (>0.70) for ROC curves and p-values (<0.05) for logistic fit. DCA showed greater net benefit from model fit than univariate analysis, treating “all,” or “none.” Training/test sets achieved comparable AUC but with higher p-values.ConclusionsPerformance of nomograms and DCA based on metrics derived from SRMP-MRI in this pilot study were comparable to those using prostate serum antigen, age, and PI-RADS.
first_indexed 2024-04-10T20:47:15Z
format Article
id doaj.art-b66370c8d2e747e6bcf27fe1a84d6623
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-10T20:47:15Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-b66370c8d2e747e6bcf27fe1a84d66232023-01-24T07:17:07ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-01-011310.3389/fonc.2023.10664981066498Pilot study for generating and assessing nomograms and decision curves analysis to predict clinically significant prostate cancer using only spatially registered multi-parametric MRIRulon Mayer0Rulon Mayer1Baris Turkbey2Peter Choyke3Charles B. Simone4Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United StatesOncoScore, Garrett Park, MD, United StatesMolecular Imaging Branch, National Institutes of Health (NIH), Bethesda, MD, United StatesMolecular Imaging Branch, National Institutes of Health (NIH), Bethesda, MD, United StatesDepartment of Radiation Oncology, New York Proton Center, New York, NY, United StatesBackgroundCurrent prostate cancer evaluation can be inaccurate and burdensome. To help non-invasive prostate tumor assessment, recent algorithms applied to spatially registered multi-parametric (SRMP) MRI extracted novel clinically relevant metrics, namely the tumor’s eccentricity (shape), signal-to-clutter ratio (SCR), and volume.PurposeConduct a pilot study to predict the risk of developing clinically significant prostate cancer using nomograms and employing Decision Curves Analysis (DCA) from the SRMP MRI-based features to help clinicians non-invasively manage prostate cancer.MethodsThis study retrospectively analyzed 25 prostate cancer patients. MP-MRI (T1, T2, diffusion, dynamic contrast-enhanced) were resized, translated, and stitched to form SRMP MRI. Target detection algorithm [adaptive cosine estimator (ACE)] applied to SRMP MRI determines tumor’s eccentricity, noise reduced SCR (by regularizing or eliminating principal components (PC) from the covariance matrix), and volume. Pathology assessed wholemount prostatectomy for Gleason score (GS). Tumors with GS >=4+3 (<=3+4) were judged as “Clinically Significant” (“Insignificant”). Logistic regression combined eccentricity, SCR, volume to generate probability distribution. Nomograms, DCA used all patients plus training (13 patients) and test (12 patients) sets. Area Under the Curves for (AUC) for Receiver Operator Curves (ROC) and p-values evaluated the performance.ResultsCombining eccentricity (0.45 ACE threshold), SCR (3, 4 PCs), SCR (regularized, modified regularization) with tumor volume (0.65 ACE threshold) improved AUC (>0.70) for ROC curves and p-values (<0.05) for logistic fit. DCA showed greater net benefit from model fit than univariate analysis, treating “all,” or “none.” Training/test sets achieved comparable AUC but with higher p-values.ConclusionsPerformance of nomograms and DCA based on metrics derived from SRMP-MRI in this pilot study were comparable to those using prostate serum antigen, age, and PI-RADS.https://www.frontiersin.org/articles/10.3389/fonc.2023.1066498/fullprostate cancermulti-parametric magnetic resonance imaging (MP-MRI)Gleason score (GS)signal-to-clutter ratio (SCR)regularizationnomograms
spellingShingle Rulon Mayer
Rulon Mayer
Baris Turkbey
Peter Choyke
Charles B. Simone
Pilot study for generating and assessing nomograms and decision curves analysis to predict clinically significant prostate cancer using only spatially registered multi-parametric MRI
Frontiers in Oncology
prostate cancer
multi-parametric magnetic resonance imaging (MP-MRI)
Gleason score (GS)
signal-to-clutter ratio (SCR)
regularization
nomograms
title Pilot study for generating and assessing nomograms and decision curves analysis to predict clinically significant prostate cancer using only spatially registered multi-parametric MRI
title_full Pilot study for generating and assessing nomograms and decision curves analysis to predict clinically significant prostate cancer using only spatially registered multi-parametric MRI
title_fullStr Pilot study for generating and assessing nomograms and decision curves analysis to predict clinically significant prostate cancer using only spatially registered multi-parametric MRI
title_full_unstemmed Pilot study for generating and assessing nomograms and decision curves analysis to predict clinically significant prostate cancer using only spatially registered multi-parametric MRI
title_short Pilot study for generating and assessing nomograms and decision curves analysis to predict clinically significant prostate cancer using only spatially registered multi-parametric MRI
title_sort pilot study for generating and assessing nomograms and decision curves analysis to predict clinically significant prostate cancer using only spatially registered multi parametric mri
topic prostate cancer
multi-parametric magnetic resonance imaging (MP-MRI)
Gleason score (GS)
signal-to-clutter ratio (SCR)
regularization
nomograms
url https://www.frontiersin.org/articles/10.3389/fonc.2023.1066498/full
work_keys_str_mv AT rulonmayer pilotstudyforgeneratingandassessingnomogramsanddecisioncurvesanalysistopredictclinicallysignificantprostatecancerusingonlyspatiallyregisteredmultiparametricmri
AT rulonmayer pilotstudyforgeneratingandassessingnomogramsanddecisioncurvesanalysistopredictclinicallysignificantprostatecancerusingonlyspatiallyregisteredmultiparametricmri
AT baristurkbey pilotstudyforgeneratingandassessingnomogramsanddecisioncurvesanalysistopredictclinicallysignificantprostatecancerusingonlyspatiallyregisteredmultiparametricmri
AT peterchoyke pilotstudyforgeneratingandassessingnomogramsanddecisioncurvesanalysistopredictclinicallysignificantprostatecancerusingonlyspatiallyregisteredmultiparametricmri
AT charlesbsimone pilotstudyforgeneratingandassessingnomogramsanddecisioncurvesanalysistopredictclinicallysignificantprostatecancerusingonlyspatiallyregisteredmultiparametricmri